These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26227124)

  • 21. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.
    Honma I; Masumori N; Sato E; Takayanagi A; Takahashi A; Itoh N; Tamagawa M; Sato MA; Tsukamoto T
    Urology; 2004 Oct; 64(4):744-8. PubMed ID: 15491713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Possibilities and limits of mistletoe therapy in cancer patients].
    Hoffmann J
    Arch Gynecol Obstet; 1987; 242(1-4):257-60. PubMed ID: 3688952
    [No Abstract]   [Full Text] [Related]  

  • 24. [Analysis of Clinical, Histopathological and Follow-Up Data on Transurethral Resections of the Bladder Performed during One Year at a University Centre].
    Otto W; Fritsche HM; Dirmeyer M; Burger M; Straub M; Rössler W; Wieland WF; Denzinger S
    Aktuelle Urol; 2010 Sep; 41(5):316-9. PubMed ID: 20669097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial comment.
    O'Donnell PH; Posadas EM
    Urology; 2011 Jan; 77(1):165-6. PubMed ID: 21195839
    [No Abstract]   [Full Text] [Related]  

  • 26. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer.
    Stein JP; Skinner DG
    BJU Int; 2003 Jul; 92(1):12-7. PubMed ID: 12823375
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic evaluation of the clinical effects of supportive mistletoe treatment within chemo- and/or radiotherapy protocols and long-term mistletoe application in nonmetastatic colorectal carcinoma: multicenter, controlled, observational cohort study.
    Friedel WE; Matthes H; Bock PR; Zänker KS
    J Soc Integr Oncol; 2009; 7(4):137-45. PubMed ID: 19883529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of recurrence in urinary bladder tumors by intravesical instillation treatment with adriamycin].
    Flamm J; Grof F
    Urologe A; 1985 Jan; 24(1):31-5. PubMed ID: 4039083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neo-adjuvant cisplatinum in locally advanced urothelial bladder cancer: a prospective randomized study of the group CUETO.
    Martinez-Piñeiro JA; Jimenez Leon J; Gonzalez Martin M; Arocena Lanz F; Ramos Roncero C; Flores N; Portillo JA; Escudero A; Jimenez Cruz F; Isorna S
    Prog Clin Biol Res; 1990; 353():95-103. PubMed ID: 2217431
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of postoperative recurrence of bladder cancer: a clinical study].
    Yang D; Li S; Wang H; Li X; Liu S; Han W; Hao J; Zhang H
    Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):464-5. PubMed ID: 11829890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on additional Iscador therapy in the management of women with surgically and radiotherapeutically treated genital carcinoma].
    Leroi R
    Gynaecologia; 1969; 167(3):158-70. PubMed ID: 4305038
    [No Abstract]   [Full Text] [Related]  

  • 33. A 20-year-old basal cell carcinoma.
    Schumacher H; Huang S
    Plast Reconstr Surg; 2005 Feb; 115(2):668-9. PubMed ID: 15692395
    [No Abstract]   [Full Text] [Related]  

  • 34. Single instillation of mitomycin C plus bacillus Calmette-Guérin (BCG) versus BCG alone in high grade non-muscle invasive bladder cancer.
    Weiss BE; Pietzak EJ; Wein AJ; Malkowicz SB; Guzzo TJ
    Can J Urol; 2015 Aug; 22(4):7876-81. PubMed ID: 26267025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adjuvant topical chemotherapy with cisplatin in superficial bladder cancer].
    Flamm J; Grof F
    Urologe A; 1986 Jan; 25(1):48-50. PubMed ID: 3962044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neoadjuvant chemotherapy: meta-analysis and interpretation of results in bladder cancer].
    Pollera CF
    Suppl Tumori; 2004; 3(4):S59-61. PubMed ID: 15206215
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recurrence prevention of papillomas of the bladder using lycurim instillation].
    Zárandy B; Szabó J; Molnár I; Sallai Z; Simon Z; Légrády J
    Z Urol Nephrol; 1984 Oct; 77(10):599-603. PubMed ID: 6549094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined therapy for patients with invasive bladder cancer].
    Startsev VIu; Karelin MI
    Vopr Onkol; 2003; 49(2):235-8. PubMed ID: 12785212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bladder cancer--resection/ablation.
    Corica FA; Keane TE
    Surg Oncol Clin N Am; 2005 Apr; 14(2):321-52. PubMed ID: 15817242
    [No Abstract]   [Full Text] [Related]  

  • 40. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study.
    Bar-Sela G; Wollner M; Hammer L; Agbarya A; Dudnik E; Haim N
    Eur J Cancer; 2013 Mar; 49(5):1058-64. PubMed ID: 23218588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.